Intercellular Communication in the Heart: Therapeutic Opportunities for Cardiac Ischemia

Trends Mol Med. 2021 Mar;27(3):248-262. doi: 10.1016/j.molmed.2020.10.002. Epub 2020 Oct 30.

Abstract

The maintenance of tissue, organ, and organism homeostasis relies on an intricate network of players and mechanisms that assist in the different forms of cell-cell communication. Myocardial infarction, following heart ischemia and reperfusion, is associated with profound changes in key processes of intercellular communication, involving gap junctions, extracellular vesicles, and tunneling nanotubes, some of which have been implicated in communication defects associated with cardiac injury, namely arrhythmogenesis and progression into heart failure. Therefore, intercellular communication players have emerged as attractive powerful therapeutic targets aimed at preserving a fine-tuned crosstalk between the different cardiac cells in order to prevent or repair some of harmful consequences of heart ischemia and reperfusion, re-establishing myocardial function.

Keywords: acute myocardial infarction; cardioprotection; extracellular vesicles; gap junctions; intercellular communication; remote ischemic conditioning.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cardiotonic Agents / pharmacology
  • Cell Communication*
  • Connexins / metabolism
  • Disease Models, Animal
  • Drug Delivery Systems
  • Extracellular Vesicles
  • Gap Junctions
  • Humans
  • Myocardial Infarction* / pathology
  • Myocardial Infarction* / therapy
  • Myocardial Ischemia / pathology
  • Myocardial Ischemia / therapy
  • Myocardium* / cytology
  • Myocardium* / pathology
  • Myocytes, Cardiac / metabolism
  • Myocytes, Cardiac / pathology
  • Signal Transduction

Substances

  • Cardiotonic Agents
  • Connexins